Latest posts
-
Uterine Fibroids and Implantation: LIF Signaling Rose After Myomectomy
Women with fibroids had about half the endometrial LIF expression of fertile controls. Levels rose after myomectomy, but the small study measured molecular signals rather than implantation, pregnancy or live birth.
-
IVF Success After Three Cycles: What a 68.2% Cumulative Live Birth Rate Means
An Australian cohort reported a 68.2% optimal cumulative live birth estimate over three IVF cycles, versus 58.7% when all women who started treatment were counted. Outcomes varied markedly by age.
-
IVF Egg Numbers and Live Birth: What One More Egg May Mean
An ESHRE conference abstract reported 5.4% higher odds of having one child and 6.5% higher odds of having two children per additional mature egg in a retrospective IVF cohort. These associations are not fixed increases in individual success probability.
-
Mitochondria and Egg Aging: What Can Treatment Change?
Mitochondria supply energy for egg maturation and early embryo development, but their role in aging does not establish a proven rejuvenation treatment. A Yale review examines supplements and mitochondrial replacement while highlighting uncertain clinical benefits and safety questions.
-
Direct Embryo Warming: Promising Mouse Data, Human Limits
A study comparing direct and conventional embryo warming found similar mouse survival, development, and live birth outcomes, with no coordinated molecular disruption detected. Its limited human embryo data do not establish clinical effectiveness or long-term safety in patients.
-
STAT3 and Implantation Failure: Why the Uterine Lining Matters
STAT3 helps regulate the uterine lining’s preparation for implantation. Human tissue and cell studies, alongside mouse experiments, offer clues to recurrent implantation failure, but do not establish a proven STAT3 test or treatment.
-
HIFU vs. Myomectomy for Fibroids: Pregnancy and Live Birth Outcomes
A five-year observational study of 332 women compared HIFU with laparoscopic myomectomy for uterine fibroids. Cumulative pregnancy rates differed, but live birth, miscarriage, recurrence and ovarian function did not differ significantly. Nonrandom treatment selection prevents conclusions that HIFU is superior.
-
Immature Eggs in IVF: What TUBB8 Reveals About Maturation Arrest
In six women with recurrent oocyte maturation arrest, TUBB8 variants disrupted the spindle needed for egg maturation. ICSI and artificial oocyte activation did not overcome the problem. This small, highly selected study does not explain all immature eggs retrieved during IVF.
-
ASFI vs ICSI: What Will the 200-Patient Fertilization Study Test?
ASFI brings sperm into contact with the egg membrane to encourage fusion. A nonrandomized study in 200 patients will compare it with PIEZO-ICSI; improved pregnancy and birth outcomes have not been established.
-
IVF and Congenital Heart Defects: What Does the Risk Mean?
A review of 35 studies found an association between assisted reproductive technology and congenital heart defects. Absolute prevalence remained low, and the evidence cannot establish that IVF itself caused the difference or support additional fetal heart screening solely because of ART in settings with standard screening.